NAD+ and 5-Amino-1MQ: Non-Peptide Research Guide
NAD+ and 5-Amino-1MQ belong to the non-peptide research compounds group, but they are different materials with different roles in the research literature. NAD+ is a dinucleotide cofactor. 5-Amino-1MQ is a small-molecule quinolinium compound studied in the context of nicotinamide N-methyltransferase (NNMT) inhibition. A connection to cellular metabolism does not make them interchangeable.
For Research Use Only. Not for human or veterinary use.
NAD+ and 5-Amino-1MQ at a glance
| Feature | NAD+ | 5-Amino-1MQ |
|---|---|---|
| Material identity | Nicotinamide adenine dinucleotide, oxidized form. | 5-Amino-1-methylquinolinium; confirm the specified salt form. |
| Research context | Cofactor and redox-related biochemical research. | Small-molecule NNMT inhibitor research. |
| Peptide? | No. | No. |
| Current labeled presentations | 500 mg and 1000 mg lyophilized vials. | 10 mg solid research material. |
| Documentation | Review the report matching the exact compound, presentation and lot. | |
What distinguishes NAD+?
The plus sign identifies the oxidized form in the NAD+/NADH redox pair. A paper measuring NADH generation is not automatically testing a commercial NAD+ vial, and a result for a related metabolite should not be relabeled as a result for NAD+.
For example, a published electrochemical study examined NAD+ reduction and subsequent enzyme-coupled conversion in a defined experimental medium. Its measurements depended on the system being studied. That is a biochemical research context, not evidence of a benefit from a retail research material. See the primary electrochemical study.
What distinguishes 5-Amino-1MQ?
5-Amino-1MQ is not a peptide or another name for NAD+. Its methylquinolinium identity and specified salt are important when comparing a product label, analytical report and publication. Keep the full material designation in the research record rather than relying on an abbreviated name alone.
A 2018 study of small-molecule NNMT inhibitors examined methylquinolinium compounds using permeability and selectivity assays, cultured adipocytes and a mouse model. The work also measured intracellular metabolites, including NAD+. Those experiments explain why NNMT inhibition and NAD+ can appear in the same research discussion. They do not make the inhibitor and the cofactor the same reagent, or verify the identity and performance of a particular supplier lot.
How to read research involving both terms
- Identify the test material: was the study evaluating NAD+, a specific NNMT inhibitor, another metabolite or a different compound?
- Identify the measurement: enzyme activity, intracellular metabolite levels and a whole-model outcome answer different questions.
- Keep the experimental context: note the model, matrix, comparator and observation period.
- Separate individual and combined evidence: a paper mentioning both terms does not establish the performance of a mixture or justify combining them.
This guide does not rank the compounds by effectiveness or translate experimental findings into human-use instructions.
Review the exact material and batch
- Match the compound name, specified chemical form, labeled vial amount and lot number.
- Read the identity method and the reported result. Do not assume that every report uses the same method.
- Distinguish chromatographic purity from measured quantity. A purity percentage alone is not a measurement of milligrams per vial.
- Check which additional attributes were actually tested. Sterility, endotoxin, residual solvents and stability should not be inferred from a purity result.
- Resolve a missing or mismatched report before treating it as evidence for the selected material.
The COA reading checklist explains general document-review principles. Its peptide-specific analytical examples should not be assumed to validate a method for these non-peptide compounds. For the separate role of hazard information, see COA vs SDS.
Product specifications and reports
Browse Non-Peptide Research Compounds, or review the individual NAD+ specifications and 5-Amino-1MQ specifications. Use the COA library to locate available batch reports and compare the identifiers with your material. Follow the product label and applicable laboratory safety documentation for storage and handling.
Frequently asked questions
Are NAD+ and 5-Amino-1MQ peptides?
No. They are grouped here as non-peptide research compounds. The shared category does not imply a shared chemical structure or experimental purpose.
Does the larger vial amount make one compound stronger?
No. The listed amounts describe different product presentations. They are not a potency comparison between the compounds.
Can a COA for one presentation verify another?
A report must be matched to the exact material and lot it documents. Do not assume that a report for one compound, vial presentation or batch verifies another.